Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tyk Medicines, Inc

Clinical trials sponsored by Tyk Medicines, Inc, explained in plain language.

TYK Medicines, Inc 2410 HKEX

Biopharmaceutical company developing oncology drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1

New pill targets cancer growth pathway in advanced tumors

Disease control Not yet recruiting

This study tests a new drug called TYK-01054 for people with advanced solid tumors that have not responded to standard treatments. The drug is taken as a capsule and works by blocking a protein (TEAD) involved in cancer growth. The trial will check safety, find the best dose, and…

Phase: PHASE1, PHASE2 • Sponsor: TYK Medicines, Inc • Aim: Disease control

Last updated Jun 27, 2026 08:06 UTC